Model
Edge
4D Molecular Therapeutics
0001833453
Filing type
4
Filing date
Jun 17, 2026
Updated
Jun 18, 2026 ยท 3:39 PM
Copy reference
Filing
4
Statement of Changes in Beneficial Ownership